2025
Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults
Du Z, Pandey A, Moghadas S, Bai Y, Wang L, Matrajt L, Singer B, Galvani A. Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults. Nature Medicine 2025, 31: 647-652. PMID: 39789324, PMCID: PMC11835734, DOI: 10.1038/s41591-024-03431-7.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusSyncytial virusRSV diseaseImpact of vaccinationBurden of respiratory syncytial virusVaccination of pregnant womenRSV-related mortalityProtein-based vaccinesVaccination of older adultsRSV vaccinePregnant womenSeasonal influenzaVaccine uptake ratesInfant hospitalizationClinical trialsPrefusion FHospital costsInfantsHealth burdenAdult immunizationVaccineOlder adultsHospitalEnhanced uptakeHigh-income countries
2011
Dengue vector control strategies in an urban setting: an economic modelling assessment
Luz PM, Vanni T, Medlock J, Paltiel AD, Galvani AP. Dengue vector control strategies in an urban setting: an economic modelling assessment. The Lancet 2011, 377: 1673-1680. PMID: 21546076, PMCID: PMC3409589, DOI: 10.1016/s0140-6736(11)60246-8.Peer-Reviewed Original ResearchConceptsCost-effectiveness ratioHerd immunityAdult controlsDengue burdenIncremental cost-effectiveness ratioDengue transmissionCost-effective interventionResource-constrained countriesProbabilistic sensitivity analysesCost-effectiveness analysisIncidence of dengueFuture dengue epidemicsImmunological effectsHealth burdenRisk of dengueVector control policiesDengue epidemicsImmunityVector control strategiesBurdenDengueAdult mosquitoesInterventionEpidemicYears
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply